I've had my eye on this for a long time and I never thought it would get this low. This is a risky play like all pharm stocks but I feel that given the history of the company it's due for a least a little shot in the arm to at least 2.30 or so. Plus some news is suppose to be released soon about one of its cancer research projects. I hope its good news. A target of around 1.90 would have bee...
NSTK:HEADING FOR $1.00 BID REAL SOON! NO MOMENTUM,NO PRODUCTS, ENIMIC VOLUME,NO PARTNERS, NO REVENUE TO SPEAK OF, LARGE EXPENSES, AND MANY FINANCIALLY DECIMATED SHAREHOLDERS ALL OVER THE PLACE. NSTK NEEDS NEW NAME, NEW SHAREHOLDERS SO MANAGEMENT CAN COLLECT SALARIES FOR ANOTHER 24 YEARS.
NSTK: BEING IN BUSINESS FOR 24 YEARS, BECOMING ACQUAINTED WITH BROKERAGE HOUSES, RESEARCH FRMS, STAR MINE ANALYSTS, AND THE REST OF THE CIRCLE OF EVERYDAY BUSINESS ASSOCIATES OF WALL STREET, IT CAN BE UNDERSTOOD HOW FUNDS, RESEARCH FIRMS, AND ANALYSTS, COULD FIND IT QUITE EASY TO PLAY FAVORITISM OR SORT OF GO WITH THE FLOW IN PARTICIPATING IN RECOMMENDING ...
About Nastech Pharmaceutical Company Inc.
- Answers.com
